Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05678673 |
Title | Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma (STELLAR-304) |
Acronym | STELLAR-304 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Exelixis |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | POL | NLD | ITA | FRA | FIN | ESP | DEU | CZE | BRA | AUS | ARG |